KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | -66.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -97.8% | 1,000 | -96.0% | 0.00% | – |
| Q1 2022 | $182,000 | -9.9% | 24,729 | -21.6% | 0.00% | – |
| Q4 2021 | $202,000 | +242.4% | 31,543 | +450.9% | 0.00% | – |
| Q2 2021 | $59,000 | -24.4% | 5,726 | -23.2% | 0.00% | – |
| Q1 2021 | $78,000 | -83.6% | 7,456 | -75.8% | 0.00% | -100.0% |
| Q4 2020 | $477,000 | +736.8% | 30,846 | +936.8% | 0.00% | – |
| Q1 2020 | $57,000 | – | 2,975 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |